Pliant Therapeutics (NASDAQ:PLRX) Rating Lowered to “Hold” at Stifel Nicolaus
Pliant Therapeutics (NASDAQ:PLRX – Get Free Report) was downgraded by equities research analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating in a research note issued on Monday, Marketbeat.com reports. Other analysts have also issued research reports about the stock. Needham & Company LLC decreased their target price on shares of Pliant […]
Pliant Therapeutics (NASDAQ:PLRX – Get Free Report) was downgraded by equities research analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating in a research note issued on Monday, Marketbeat.com reports. Other analysts have also issued research reports about the stock. Needham & Company LLC decreased their target price on shares of Pliant […]
